Kinomic profiling approach identifies Trk as a novel radiation modulator

Area of Science:

• Oncology
• Molecular Biology
• Cellular Biology

Background:

• Ionizing radiation is a cornerstone of cancer therapy, used in over half of all patients.
• Understanding radiation response and resistance mechanisms is crucial for developing improved cancer treatments.

Purpose of the Study:

• To investigate the mechanisms of radiation response in vascular endothelial cells.
• To identify novel therapeutic targets for modulating radiation sensitivity.

Main Methods:

• Utilized a high-content peptide array platform for multiplex kinase assays with real-time kinetic readout.
• Applied the technology to irradiated human umbilical vein endothelial cells (HUVEC).

Main Results:

• Identified 49 differentially tyrosine phosphopeptides affected by irradiation within 1 hour.
• Observed transient activation of Tropomyosin receptor kinase (Trk) family members, TrkA and TrkB, between 2 and 15 minutes post-irradiation.
• TrkA/TrkB inhibition protected HUVEC from radiation damage, while TrkA stimulation enhanced radiation effects.

Conclusions:

• The study successfully identified rapid kinase activity changes and novel targets like TrkA.
• TrkA inhibition demonstrated radioprotective effects by enhancing DNA repair.
• TrkA stimulation via gambogic amide led to radiation sensitization, highlighting its therapeutic potential.